Parkway Medical Center

Birmingham, Alabama 35215

2 studies enrolling now · 33 studies all time

What they study most

Albuminuria, Alcohol Use Disorder, Alzheimer Disease, Alzheimer's Disease, Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Constipation, Chronic Lower Back Pain, Chronic Pain, Chronic Sinusitis, Colorectal Cancer, Diabetes Mellitus, Non-Insulin-Dependent

Studies at this site

• Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD — Recruiting now
• A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder — Recruiting now
• Pelacarsen Roll-over Extension Program — Recruiting now
• A Study of DII235 in Adults With Elevated Lipoprotein(a) — Running, not enrolling
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
• An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients. — Completed
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling
• Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy. — Completed
• OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder — Completed
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus — Completed
• Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C" — Completed
• Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C" — Completed
• Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain — Completed
• Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder — Completed
• Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence — Completed
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
• Long-term Open-Label Safety Study to Evaluate EN3409 — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus — Completed
• Extension Study for 2993-112 — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin — Completed
• A 2-Month Safety Follow-Up Trial — Completed
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes — Completed
• Safety and Tolerability of Buprenorphine/Naloxone Film Strips — Completed
• Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain — Stopped early
• Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. — Stopped early
• Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension. — Stopped early
• Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain — Completed
• Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy — Completed
• Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy — Completed
• Amphotericin B Suspension in Refractory Chronic Sinusitis — Completed